 | |
| Clinical data | |
|---|---|
| ATC code | |
| Identifiers | |
| |
| CAS Number |
|
| PubChemCID | |
| ChemSpider |
|
| UNII | |
| KEGG |
|
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C11H15BrN2O3 |
| Molar mass | 303.156 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Narcobarbital (Pronarcon) is abarbiturate derivative developed in 1932 by Carl Heinrich Friedrich Boedecker and Heinrich Gruber Schoneberg, assignors to the firm J. D. Riedel-E. de Haën AG, Berlin, Germany. Later, in 1937, may, was patented in United States.[1] It is an N-methylated derivative ofpropallylonal and has similarsedative effects. It is still used inveterinary medicine for inducingsurgicalanaesthesia.[2]
